After protracted debate over federal guidelines for prescribing opioids, the Centers for Disease Control and Prevention has clarified its position, stating that its three-year-old recommendations were not intended to deny clinically appropriate treatment to patients who suffer acute or chronic pain from conditions such as cancer and sickle cell disease.

Those guidelines, which focus on chronic pain except for cancer and end-of-life care, target primary care physicians because family doctors write the vast majority of prescriptions for painkillers. Doctors were also advised to prescribe opioids only after other therapies have failed and rely on the lowest possible doses. The guidelines were issued in March 2016.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy